Company attributes
Industry
B2X
Founder
AngelList URL
Legal Name
Vertex Pharmaceuticals Incorporated0
Legal classification
Number of Employees (Ranges)
1,001 – 5,0000
Email Address
investorinfo@vrtx.com0
mediainfo@vrtx.com0
Phone Number
+161734161000
Number of Employees
4,1470
Full Address
50 NORTHERN AVE BOSTON, MA 02210 UNITED STATES0
CIK Number
Place of Incorporation
DUNS Number
602478257
IRS Number
43,039,129
Founded Date
1989
0Competitors
Stock Symbol
VRTX
Exchange
Key People
Patents Assigned (Count)
812
Wellfound ID
Technologies Used
Country
Headquarters
Other attributes
Company Operating Status
Active
SIC Code
2,834
Ticker Symbol
VRTX0
Wikidata ID
Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders. Vertex’s product Trikafta was approved by the USFDA in 2019 for treatment of cystic fibrosis. Other approved cystic fibrosis medicines from Vertex include Symdeko, Orkambi and Kalydeco.
Vertex and CRISPR Therapeutics are collaborating with their treatment, CTX001, made from a patient’s own stem cells harvested and edited using CRISPR technology to increase fetal hemoglobin levels to treat transfusion-dependent beta thalassemia and sickle cell disease.
Timeline
No Timeline data yet.
